Transcriptomic Responses to Polymyxin B and Analogues in Human Kidney Tubular Cells

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2023 Feb 25

PMID 36830325

Authors

Mengyao Li

Mohammad A K Azad

Philip E Thompson

Kade D Roberts

Tony Velkov

Yan Zhu

Jian Li

Affiliations

Soon will be listed here.

Abstract

Polymyxins are last-line antibiotics for the treatment of Gram-negative 'superbugs'. However, nephrotoxicity can occur in up to 60% of patients administered intravenous polymyxins. The mechanisms underpinning nephrotoxicity remain unclear. To understand polymyxin-induced nephrotoxicity, human renal proximal tubule cells were treated for 24 h with 0.1 mM polymyxin B or two new analogues, FADDI-251 or FADDI-287. Transcriptomic analysis was performed, and differentially expressed genes (DEGs) were identified using ANOVA (FDR < 0.2). Cell viability following treatment with polymyxin B, FADDI-251 or FADDI-287 was 66.0 ± 5.33%, 89.3 ± 3.96% and 90.4 ± 1.18%, respectively. Transcriptomics identified 430, 193 and 150 DEGs with polymyxin B, FADDI-251 and FADDI-287, respectively. Genes involved with metallothioneins and Toll-like receptor pathways were significantly perturbed by all polymyxins. Only polymyxin B induced perturbations in signal transduction, including FGFR2 and MAPK signaling. SIGNOR network analysis showed all treatments affected essential regulators in the immune system, autophagy, cell cycle, oxidative stress and apoptosis. All polymyxins caused significant perturbations of metal homeostasis and TLR signaling, while polymyxin B caused the most dramatic perturbations of the transcriptome. This study reveals the impact of polymyxin structure modifications on transcriptomic responses in human renal tubular cells and provides important information for designing safer new-generation polymyxins.

References

Dailey L, Ambrosetti D, Mansukhani A, Basilico C . Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005; 16(2):233-47. DOI: 10.1016/j.cytogfr.2005.01.007. View

Vivanco I, Sawyers C . The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002; 2(7):489-501. DOI: 10.1038/nrc839. View

Zavascki A, Goldani L, Cao G, Superti S, Lutz L, Barth A . Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis. 2008; 47(10):1298-304. DOI: 10.1086/592577. View

Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2000; 103(2):211-25. DOI: 10.1016/s0092-8674(00)00114-8. View

Coyle P, Philcox J, Carey L, Rofe A . Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002; 59(4):627-47. PMC: 11337511. DOI: 10.1007/s00018-002-8454-2. View

Eswarakumar V, Lax I, Schlessinger J . Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005; 16(2):139-49. DOI: 10.1016/j.cytogfr.2005.01.001. View

Smyth G, Speed T . Normalization of cDNA microarray data. Methods. 2003; 31(4):265-73. DOI: 10.1016/s1046-2023(03)00155-5. View

Velkov T, Thompson P, Nation R, Li J . Structure--activity relationships of polymyxin antibiotics. J Med Chem. 2009; 53(5):1898-916. PMC: 2907661. DOI: 10.1021/jm900999h. View

Lu H, Jin W, Sun J, Feng L, Lan H, Shen Q . New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling. FEBS Lett. 2014; 588(18):3322-6. DOI: 10.1016/j.febslet.2014.07.014. View

10.

Randall R, Bridi G, SETTER J, Brackett N . Recovery from colistimethate nephrotoxicity. Ann Intern Med. 1970; 73(3):491-2. DOI: 10.7326/0003-4819-73-3-491. View

11.

Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K . Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2):153-83. DOI: 10.1210/edrv.22.2.0428. View

12.

Chiaverini N, De Ley M . Protective effect of metallothionein on oxidative stress-induced DNA damage. Free Radic Res. 2010; 44(6):605-13. DOI: 10.3109/10715761003692511. View

13.

Dai C, Li J, Tang S, Li J, Xiao X . Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother. 2014; 58(7):4075-85. PMC: 4068542. DOI: 10.1128/AAC.00070-14. View

14.

Han M, Dai D, Yousafzai N, Wang F, Wang H, Zhou Q . CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer. Oncotarget. 2017; 8(61):103557-103567. PMC: 5732750. DOI: 10.18632/oncotarget.21581. View

15.

Yousef J, Chen G, Hill P, Nation R, Li J . Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother. 2011; 55(9):4044-9. PMC: 3165279. DOI: 10.1128/AAC.00328-11. View

16.

Azad M, Akter J, Rogers K, Nation R, Velkov T, Li J . Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells. Antimicrob Agents Chemother. 2015; 59(4):2136-43. PMC: 4356794. DOI: 10.1128/AAC.04869-14. View

17.

Falagas M, Kasiakou S . Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005; 40(9):1333-41. DOI: 10.1086/429323. View

18.

Jiang X, Zhang S, Azad M, Roberts K, Wan L, Gong B . Structure-Interaction Relationship of Polymyxins with the Membrane of Human Kidney Proximal Tubular Cells. ACS Infect Dis. 2020; 6(8):2110-2119. PMC: 7485602. DOI: 10.1021/acsinfecdis.0c00190. View

19.

Azad M, Finnin B, Poudyal A, Davis K, Li J, Hill P . Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells. Antimicrob Agents Chemother. 2013; 57(9):4329-4335. PMC: 3754291. DOI: 10.1128/AAC.02587-12. View

20.

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View